Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 4
2005 5
2006 11
2007 9
2008 11
2009 13
2010 17
2011 14
2012 21
2013 17
2014 15
2015 18
2016 23
2017 29
2018 26
2019 28
2020 17
2021 31
2022 11
2023 26
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, Jüni P, Zuo F, Mistry N, Thorpe KE, Goldenberg RM, Yan AT, Connelly KA, Verma S. Mazer CD, et al. Among authors: yan at. Circulation. 2020 Feb 25;141(8):704-707. doi: 10.1161/CIRCULATIONAHA.119.044235. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707794 No abstract available.
In-center nocturnal hemodialysis.
Jakubovic BD, Yan AT, Wald R. Jakubovic BD, et al. Among authors: yan at. Semin Dial. 2014 Mar;27(2):179-87. doi: 10.1111/sdi.12184. Semin Dial. 2014. PMID: 24738147 Review.
Reply.
Sarak B, Wald R, Yan AT. Sarak B, et al. Among authors: yan at. J Hypertens. 2017 Dec;35(12):2553-2554. doi: 10.1097/HJH.0000000000001552. J Hypertens. 2017. PMID: 29095237 No abstract available.
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Connelly KA, Mazer CD, Puar P, Teoh H, Wang CH, Mason T, Akhavein F, Chang CW, Liu MH, Yang NI, Chen WS, Juan YH, Opingari E, Salyani Y, Barbour W, Pasricha A, Ahmed S, Kosmopoulos A, Verma R, Moroney M, Bakbak E, Krishnaraj A, Bhatt DL, Butler J, Kosiborod MN, Lam CSP, Hess DA, Rizzi Coelho-Filho O, Lafreniere-Roula M, Thorpe KE, Quan A, Leiter LA, Yan AT, Verma S. Connelly KA, et al. Among authors: yan at. Circulation. 2023 Jan 24;147(4):284-295. doi: 10.1161/CIRCULATIONAHA.122.062769. Epub 2022 Nov 6. Circulation. 2023. PMID: 36335517 Clinical Trial.
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA. Verma S, et al. Among authors: yan at. Circulation. 2019 Nov 19;140(21):1693-1702. doi: 10.1161/CIRCULATIONAHA.119.042375. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434508 Clinical Trial.
Stress cardiac MRI in stable coronary artery disease.
Ge Y, Deva DP, Connelly KA, Yan AT. Ge Y, et al. Among authors: yan at. Curr Opin Cardiol. 2020 Sep;35(5):566-573. doi: 10.1097/HCO.0000000000000776. Curr Opin Cardiol. 2020. PMID: 32649360 Review.
304 results